1. Mechanisms of Oxidized LDL-Mediated Endothelial Dysfunction and Its Consequences for the Development of Atherosclerosis
   Hui Jiang et al, 2022, Frontiers in Cardiovascular Medicine CrossRef
2. Trichostatin D as a Novel KLF2 Activator Attenuates TNFα-Induced Endothelial Inflammation
   Lijuan Lei et al, 2022, International Journal of Molecular Sciences CrossRef
3. Oxidized-LDL Deteriorated the Renal Residual Function and Parenchyma in CKD Rat through Upregulating Epithelial Mesenchymal Transition and Extracellular Matrix-Mediated Tubulointerstitial Fibrosis—Pharmacomodulation of Rosuvastatin
   Pei-Hsun Sung et al, 2022, Antioxidants CrossRef
4. PTP1B inhibition ameliorates inflammatory injury and dysfunction in ox‑LDL‑induced HUVECs by activating the AMPK/SIRT1 signaling pathway via negative regulation of KLF2
   Yunfeng Zhang et al, 2022, Experimental and Therapeutic Medicine CrossRef
5. The Role of KLF2 in the Regulation of Atherosclerosis Development and Potential Use of KLF2-Targeted Therapy
   Siarhei A. Dabravolski et al, 2022, Biomedicines CrossRef
6. IRF2BP2 Mutation Is Associated with Increased STAT1 and STAT5 Activation in Two Family Members with Inflammatory Conditions and Lymphopenia
   Maaria Palmroth et al, 2021, Pharmaceuticals CrossRef